Overall impact
B (71)

Commentary

Arvana is a strong overall performer. With a 'B' rating of 71.0 for overall impact (84th percentile compared to all companies), Arvana ranks 48th out of 154 industry peers, behind Adamis Pharmaceuticals, Benitec Biopharma, Aquinox Pharmaceuticals and 44 others, and ahead of Assertio Therapeutics, Evolus, DiaMedica Therapeutics and 103 others. On top material causes for Arvana's industry (Pharmaceuticals & Biotech), Arvana performs well in Disease Eradication (96.4 score), Access to Affordable Healthcare (95.9), Child and Maternal Health (92.3) and 2 other causes where it received an 'A' score and performs poorly in Disaster Readiness and Effective Aid (39.3 score), Accountable Institutions (39.0), Reduced Green House Gas Emissions (24.8) and 1 other cause where it received a 'D' or 'F' score.
Impact
Cause AVNI
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1977
Employees
1
Sector
Health Care
Industry
Pharmaceuticals
Sub-industry
Pharmaceuticals
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
Ut, United States
Share classes
AVNI
Description
Arvana Inc. provides fishing charter services. The company offers inshore/coastal fishing boat charter services and offshore fishing boat charter services. It also provides sight-seeing fishing boat charter services and custom fishing boat charter services. In addition, the company operates a private dock in Palmetto, Florida. The company was formerly known as Turinco, Inc. and changed its name to Arvana Inc. in July 2006. Arvana Inc. was incorporated in 1977 and is based in Salt Lake City, Utah.
Material causes
Ethos considers the following causes material for Arvana, based on its industry sub-industry Pharmaceuticals. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.